Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03673098 · ClinicalTrials.gov registry record · NA
The BRIgHT Program: Building Resilience in HIV Together
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT03673098: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03673098 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03673098, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
This is the second phase of a two-part study. In the first phase (Protocol ID: R34AT009170), the investigators refined and piloted the Relaxation Response Resiliency (3RP) intervention for women age 50 and over who are living with HIV, a group especially burdened by stressors related both to aging and to living with chronic disease. In this part of the study, the investigators will use data from the first phase to further adapt the intervention manual, and test the final product via a small randomized controlled trial in the same population.
Interventions
- BEHAVIORAL Adapted 3RP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2018-11-05 |
| Est. Completion | 2021-04-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03673098
The ClinicalTrials.gov registry entry for NCT03673098 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Adapted 3RP is the first listed.
NCT03673098 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03673098 about?
NCT03673098 is a clinical study titled "The BRIgHT Program: Building Resilience in HIV Together". This is the second phase of a two-part study. In the first phase (Protocol ID: R34AT009170), the investigators refined and piloted the Relaxation Response Resiliency (3RP) intervention for women age 50 and over who are living with HIV, a group especially burdened by stressors related both to aging a...
What is the current status of trial NCT03673098?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2018-11-05. Estimated completion is 2021-04-14.
What interventions are being tested in trial NCT03673098?
The interventions under investigation include: Adapted 3RP (BEHAVIORAL).
Who is sponsoring clinical trial NCT03673098?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.